|
Market Closed -
Nasdaq
16:00:00 2026-10-30 EDT
|
5-day change | 1st Jan Change | ||
| 6.310 USD | -3.30% |
|
+26.71% | -55.53% |
| 09-03 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NEXTCURE, INC. | Bio Therapeutic Drugs | -3.30% | +26.71% | -55.53% | -49.92% | -93.90% | 28.88M |  | | |
- Stock Market
- Stocks
- NXTC Stock
- Charts NextCure, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
